Nasal Spray Congestion Relief Lil' Drug Store ® Products

Manufacturer: Lil' Drug Store Products, Inc
Effective date: 2024-12-31
Label type: HUMAN OTC DRUG LABEL
Version: 7
Source: full-release
Hydrated at: 2026-06-01 00:50:01

Label at a glance#

ProductCongestion Relief Lil Drug Store Products

Active ingredientOXYMETAZOLINE HYDROCHLORIDE

Label structure11 sections

Indications and uses

Temporarily relieves nasal congestion due to: common cold hay fever upper respiratory allergies Shrinks swollen nasal membranes so you can breathe more freely

Dosage and administration

adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period. children under 6 years of age: consult a doctor To spray, squeeze bottle quickly and firmly. Do not tilt head backward while spraying. Wipe nozzle clean after use.

Storage and handling

store between 20° to 25°C (68° to 77°F) retain carton for future reference on full labeling

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-877-507-6516

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Oxymetazoline Hydrochloride 0.05%

Purpose

OTC - PURPOSE SECTION

Nasal decongestant

Uses

INDICATIONS & USAGE SECTION

Temporarily relieves nasal congestion due to:
- common cold
- hay fever
- upper respiratory allergies
Shrinks swollen nasal membranes so you can breathe more freely

Warnings

WARNINGS SECTION

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

heart disease
high blood pressure
diabetes
thyroid disease
trouble urinating due to an enlarged prostate gland

When using this product

OTC - WHEN USING SECTION

do not use more than directed
do not use for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen.
temporary discomfort such as burning, stinging, sneezing or an increase in nasal discharge may occur.
use of this container by more than one person may spread infection.

OTC - STOP USE SECTION

Stop use and ask a doctor if symptoms persist.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.
children under 6 years of age: consult a doctor

To spray, squeeze bottle quickly and firmly. Do not tilt head backward while spraying. Wipe nozzle clean after use.

Other information

STORAGE AND HANDLING SECTION

store between 20° to 25°C (68° to 77°F)
retain carton for future reference on full labeling

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzalkonium chloride solution, edetate disodium, polyethylene glycol, povidone, propylene glycol, purified water, sodium phosphate monobasic, sodium phosphate dibasic

Questions or comments

OTC - QUESTIONS SECTION

call toll-free 1-877-507-6516 (M-F 8AM-4:30PM CST)

SPL UNCLASSIFIED SECTION

Product distributed by:
Lil' Drug Store Products, Inc.
9300 Earhart Lane SW
Cedar Rapids, IA 52404

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

QUALITY

⋆GUARANTEED⋆

Compare to the Active

Ingredient in Afrin®*

Original

Nasal Spray

Oxymetazoline HCl 0.05% Nasal Solution

Nasal Decongestant

Congestion Relief

Fast
Powerful
Long-lasting

12 hour
relief

1 FL OZ

(30 mL)

Lil'

Drug Store ^®

PDP/Package

Bottle Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1000990	oxymetazoline HCl 0.05 % Nasal Spray	PSN	7
1000990	oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray	SCD	7
1000990	oxymetazoline hydrochloride 0.05 % Nasal Spray	SY	7

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
OXYMETAZOLINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
e67be450-f8e4-4bc1-88bd-1259d379f55f	Product name	1	20210127
c53f3286-4062-4cf5-8355-399519c639a6	Product name	1	20170424
a993dfc5-f219-4460-bde6-30dd724d9ef0	Product name	1	20160818

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
66715-6860-4	Congestion ReliefLil Drug Store Products	30 mL in 1 BOTTLE, SPRAY	SPRAY	30		7
66715-6860-4	Congestion ReliefLil Drug Store Products	1 in 1 CARTON	SPRAY	1		7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
66715-6860	CONGESTION RELIEF LIL DRUG STORE PRODUCTS (OXYMETAZOLINE HYDROCHLORIDE) SPRAY [LIL' DRUG STORE PRODUCTS, INC]	7	Current NDC, Legacy NDC, 2 package rows	20250101_8fca348c-ecb6-4a91-89dd-8bd4c05ac745.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Oxymetazoline Hydrochloride	ACTIVE INGREDIENT	K89MJ0S5VY	1
Oxymetazoline	ACTIVE MOIETY	8VLN5B44ZY	1
Benzalkonium Chloride	INACTIVE INGREDIENT	F5UM2KM3W7	1
Edetate Disodium	INACTIVE INGREDIENT	7FLD91C86K	1
Glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	1
Polyethylene Glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	1
Povidones	INACTIVE INGREDIENT	FZ989GH94E	1
Propylene Glycol	INACTIVE INGREDIENT	6DC9Q167V3	1
Sodium Phosphate, Dibasic, Anhydrous	INACTIVE INGREDIENT	22ADO53M6F	1
Sodium Phosphate, Monobasic, Anhydrous	INACTIVE INGREDIENT	KH7I04HPUU	1
Water	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

Congestion Relief Lil Drug Store Products
Oxymetazoline Hydrochloride
BENZALKONIUM CHLORIDE
EDETATE DISODIUM
GLYCERIN
POLYETHYLENE GLYCOL, UNSPECIFIED
POVIDONE, UNSPECIFIED
PROPYLENE GLYCOL
WATER
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM
OXYMETAZOLINE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
66715-6860	66715-6860-4

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
BENZALKONIUM CHLORIDE	F5UM2KM3W7	IACT
EDETATE DISODIUM	7FLD91C86K	IACT
GLYCERIN	PDC6A3C0OX	IACT
POLYETHYLENE GLYCOL, UNSPECIFIED	3WJQ0SDW1A	IACT
POVIDONE, UNSPECIFIED	FZ989GH94E	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
WATER	059QF0KO0R	IACT
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	3980JIH2SW	IACT
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM	GR686LBA74	IACT
OXYMETAZOLINE HYDROCHLORIDE	K89MJ0S5VY	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 152 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Propylene Glycol	PROPYLENE GLYCOL	6DC9Q167V3	SPRAY / NASAL		5 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	TABLET, FOR SUSPENSION / ORAL	2 mg		Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	CREAM / VAGINAL	ADJ PH		Exact identifier — unii candidate 82 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	GEL / TOPICAL		6 mg	Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	TABLET, CHEWABLE / ORAL		48 mg	Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Dibasic, Anhydrous	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	SPRAY / NASAL		1 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	SOLUTION / OPHTHALMIC	0.78 %w/v		Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	17 mg		Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	DROPS / AURICULAR (OTIC)	1.1 %w/w		Exact identifier — unii candidate 82 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	18.81 mg		Exact identifier — unii candidate 82 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	FILM, SOLUBLE / BUCCAL	0.03 mg		Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	CAPSULE, DELAYED RELEASE / ORAL	NA		Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR		161 mg	Exact identifier — unii candidate 82 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	SOLUTION / AURICULAR (OTIC)	0.13 %w/w		Exact identifier — unii candidate 82 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	INJECTION, SOLUTION / INTRAVENOUS	0.62 %w/v		Exact identifier — unii candidate 82 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	INJECTION, SUSPENSION / INTRALESIONAL		10 mg	Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	SUSPENSION/ DROPS / OPHTHALMIC	0.6 %w/v		Exact identifier — unii candidate 60 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	SUSPENSION / OPHTHALMIC	1.8 %w/v		Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS	1.1 mg		Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	SYSTEM / TOPICAL		41 mg	Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	FILM, SOLUBLE / BUCCAL	0.03 mg		Exact identifier — unii candidate 82 equally ranked IID candidates
Benzalkonium Chloride	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SPRAY / NASAL		1 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	TABLET / ORAL		216 mg	Exact identifier — unii candidate 60 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	TABLET / ORAL		216 mg	Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	INJECTION, SOLUTION / INTRAMUSCULAR	0.62 %w/v		Exact identifier — unii candidate 82 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	LOTION / TOPICAL	0.2 %w/w		Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	SUSPENSION / OPHTHALMIC	1.8 %w/v		Exact identifier — unii candidate 60 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	SOLUTION / ORAL		3000 mg	Exact identifier — unii candidate 60 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	TABLET, FILM COATED / ORAL	240 mg		Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Dibasic, Anhydrous	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	SPRAY / NASAL		1 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	SHAMPOO, SUSPENSION / TOPICAL	1 %w/v		Exact identifier — unii candidate 82 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	GEL / TOPICAL		6 mg	Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	SYSTEM / TOPICAL		41 mg	Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	FILM / BUCCAL	1.09 mg		Exact identifier — unii candidate 82 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	INJECTION / INTRAVENOUS	12.8 mg		Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	TABLET, FILM COATED / ORAL	240 mg		Exact identifier — unii candidate 60 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		350 mg	Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	SHAMPOO, SUSPENSION / TOPICAL	1 %w/v		Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	TABLET, CHEWABLE / ORAL		48 mg	Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	SOLUTION / TOPICAL	0.47 %w/v		Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	CAPSULE, COATED PELLETS / ORAL	10.03 mg		Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	SUSPENSION / ORAL		65 mg	Exact identifier — unii candidate 82 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	0.2 mg		Exact identifier — unii candidate 82 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	TABLET, EXTENDED RELEASE / ORAL		62 mg	Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	TABLET, COATED / ORAL	49.2 mg		Exact identifier — unii candidate 60 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	INJECTION / INTRAMUSCULAR	0.2 %w/v		Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	INSERT / INTRAOCULAR	0.01 mg		Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 60 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	FILM, EXTENDED RELEASE / TRANSDERMAL	NA		Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	INJECTION, SUSPENSION / INTRA-ARTICULAR		13 mg	Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	SUSPENSION / AURICULAR (OTIC)	NA		Exact identifier — unii candidate 60 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	SUSPENSION / ORAL	20 mg/5ml		Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	SOLUTION / INTRAVENOUS	40 mg		Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	TROCHE / ORAL	30 mg		Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	INJECTION, SUSPENSION / INTRASYNOVIAL		10 mg	Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	TABLET / SUBLINGUAL	6 mg		Exact identifier — unii candidate 60 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	INJECTION, SOLUTION / INTRAVENOUS	0.62 %w/v		Exact identifier — unii candidate 82 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	SOLUTION / AURICULAR (OTIC)	0.13 %w/w		Exact identifier — unii candidate 82 equally ranked IID candidates
Sodium Phosphate, Monobasic, Anhydrous	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	KH7I04HPUU	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	18.81 mg		Exact identifier — unii candidate 82 equally ranked IID candidates
Povidones	POVIDONE	FZ989GH94E	CAPSULE, DELAYED RELEASE PELLETS / ORAL		32 mg	Exact identifier — unii candidate 60 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Congestion Relief Lil Drug Store Products	OXYMETAZOLINE HYDROCHLORIDE	Lil' Drug Store Products, Inc	8fca348c-ecb6-4a91-89dd-8bd4c05ac745	2024-12-31	Warnings	Exact identifier ndc (package): 66715-6860-4 ndc (product): 66715-6860 ndc11 (package): 66715686004 spl id: 2a92670f-80b1-abdb-e063-6294a90a6342 spl set id: 8fca348c-ecb6-4a91-89dd-8bd4c05ac745

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.